[go: up one dir, main page]

BR9610211A - Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel - Google Patents

Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel

Info

Publication number
BR9610211A
BR9610211A BR9610211-0A BR9610211A BR9610211A BR 9610211 A BR9610211 A BR 9610211A BR 9610211 A BR9610211 A BR 9610211A BR 9610211 A BR9610211 A BR 9610211A
Authority
BR
Brazil
Prior art keywords
meta
pharmaceutical compositions
compositions based
glyceryl poly
acrylate
Prior art date
Application number
BR9610211-0A
Other languages
Portuguese (pt)
Inventor
Daniel Greff
Original Assignee
Stoa Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stoa Sa filed Critical Stoa Sa
Priority to BR9610211-0A priority Critical patent/BR9610211A/en
Publication of BR9610211A publication Critical patent/BR9610211A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção para "COMPOSIçõES FARMACEUTICAS BASEADAS EM GEL TIPO GLICERIL POLI(META) ACRILATO". A invenção revela o uso de composições farmacêuticas baseadas em gel tipo gliceril poli(meta)acrilato, localmente aplicadas para tratamento de vários sintomas e prevenção de certas condições patológicas: úlceras varicoses, secura e infecção vaginal (candidoses), scars, oedemas inflamatórios, mordidas de insetos, queimaduras leves, queimaduras pós-radioterapia, doenças virais (hérpes), doenças sexualmente transmitidas (em particular AIDS). Os géis são caracterizados por um pó de forte hidratação, uma capacidade de absorção muito alta, e segurança absoluta.Invention Patent for "PHARMACEUTICAL COMPOSITIONS BASED ON GEL TYPE GLYCERYL POLY (META) ACRYLATE". The invention reveals the use of pharmaceutical compositions based on glyceryl poly (meta) acrylate gel, locally applied to treat various symptoms and prevent certain pathological conditions: varicose ulcers, dryness and vaginal infection (candidosis), scars, inflammatory edema, bites of insects, mild burns, post-radiotherapy burns, viral diseases (herpes), sexually transmitted diseases (in particular AIDS). Gels are characterized by a highly hydrating powder, a very high absorption capacity, and absolute safety.

BR9610211-0A 1996-06-12 1996-06-12 Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel BR9610211A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9610211-0A BR9610211A (en) 1996-06-12 1996-06-12 Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1996/000886 WO1997047310A1 (en) 1996-06-12 1996-06-12 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
BR9610211-0A BR9610211A (en) 1996-06-12 1996-06-12 Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel

Publications (1)

Publication Number Publication Date
BR9610211A true BR9610211A (en) 1999-12-21

Family

ID=9488483

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610211-0A BR9610211A (en) 1996-06-12 1996-06-12 Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel

Country Status (6)

Country Link
EP (1) EP0843556A1 (en)
JP (1) JPH11511180A (en)
KR (1) KR19990036340A (en)
AU (1) AU6309296A (en)
BR (1) BR9610211A (en)
WO (1) WO1997047310A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201585T1 (en) 1998-02-12 2001-06-15 Oreal USE OF 1,2-PENTANEDIOL IN A COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING FILM-FORMING POLYMER PARTICLES IN AQUEOUS DISPERSION AND COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING THE ABOVE INGREDIENTS
DE60143566D1 (en) * 2000-03-07 2011-01-13 Rush Presbyterian St Luke Compositions and their use for capturing and inactivating pathogenic microbes and spermatozoa
DK1363617T3 (en) * 2001-01-16 2009-01-26 Hans Brinch Lyster Cyanoacrylate compositions for therapeutic treatment of wounds requiring revision
CA2463384A1 (en) * 2001-10-12 2003-04-17 Cns, Incorporated Hydrating nasal gel and applicator
EP1945307B1 (en) 2005-10-11 2013-03-27 DPT Laboratories, LTD. Surfactant-free dispersions, compositions, and use in topical formulations
FR2973701B1 (en) 2011-04-06 2013-10-04 Biopass S A COMPOSITION FOR TOPICAL APPLICATION
EP2803354B1 (en) * 2013-05-14 2015-03-04 NajöPharm GmbH i.G. Combination of polyacrylic acid and 2-amino-2-methylpropanol for use in the treatment of Herpes infections
FR3050640B1 (en) * 2016-04-28 2020-02-21 Biopass PHARMACEUTICAL PRODUCT
WO2021259215A1 (en) 2020-06-22 2021-12-30 Rht Limited Antiseptic compositions
US20230301884A1 (en) * 2020-06-22 2023-09-28 Rht Limited Antiseptic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (en) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL CONTAINING ACETYLSALICYLIC ACID
CA1305069C (en) * 1987-03-11 1992-07-14 John Cornell Wound dressings in sheet or gelled paste form
GB8910076D0 (en) * 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
GB9002290D0 (en) * 1990-02-01 1990-03-28 Procter & Gamble Cosmetic compositions
FR2682296B1 (en) * 1991-10-14 1993-11-12 Sederma Sa NOVEL COSMETIC COMPOSITIONS CONTAINING POLYMERIC GELS.

Also Published As

Publication number Publication date
WO1997047310A1 (en) 1997-12-18
JPH11511180A (en) 1999-09-28
KR19990036340A (en) 1999-05-25
EP0843556A1 (en) 1998-05-27
AU6309296A (en) 1998-01-07

Similar Documents

Publication Publication Date Title
BR9707325A (en) Process for the treatment of an affected patient with an il-1-mediated disease, pharmaceutical composition and use
ATE538177T1 (en) WOUND GELS
BRPI9908182B8 (en) wound healing matrix protein compositions
UA41989C2 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL FOR THE TREATMENT OF SKIN DISEASES AND A METHOD OF TREATMENT OF INFECTED SKIN
BR9910864A (en) Anti-inflammatory compounds for inhibiting cell adhesion
PT772600E (en) IMIDAZOLYL COMPOUNDS SUBSTITUTED IN POSTS 1 AND 2 FOR THE TREATMENT OF INFLAMMATION
FI972642L (en) Galenic unit composition for topical use for contraception and/or for combating sexually transmitted diseases and/or HIV
ES2182915T3 (en) FACTOR PURIFICATION PROCEDURE VIII
CA2293470A1 (en) Benzimidazole derivatives
ATE526956T1 (en) VIRUCIDAL COMPOSITIONS
PT1079806E (en) PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY, ANTI-SEPTIC AGENTS AND / OR WOUND HEALING PROMOTION AGENTS, IN THE SUPERIOR AND / OR HEARING RESPIRATORY TRACT
DK1071439T3 (en) Hip formulations as anti-inflammatory herbal medicine for the relief / reduction of symptoms associated with inflammation and arthritis
BR9610211A (en) Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel
ATE316822T1 (en) SOLID OR SEMI-SOLID HYDROCARBON GELS
BR9509590A (en) Application of sod in liposomes
EA200000911A1 (en) NEW CRYSTAL FORMS OF ANTI-VIRUS COMPOUND OF BENZIMIDAZOLE
ATE111735T1 (en) USE OF THE ACTIVE INGREDIENTS AZELASTINE AND GLYCERINE ETHERS TO COMBAT PSORIASIS DISEASES.
DK1401422T3 (en) Halogen-containing composition, process for its preparation and uses thereof
IS2860B (en) Antiviral formulations
Fanta et al. Contact dermatitis from tromantadine hydrochloride.
ATE152356T1 (en) TOPICAL PREPARATION FOR BETTER HEALING OF HERPES INJURIES
WO1998046240A1 (en) Topical treatment of skin diseases and eye afflictions
DE60135454D1 (en) PHARMACEUTICAL GEL COMPOSITION
KR880005920A (en) Leukocyte interferon composition and skin treatment in the human body
US5977176A (en) Compositions for the treatment of warts and herpes

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law